Carbamazepine

Carbamazepine

Products
Carbamazepine
Carbamazepine

Information

Therapeutic Area: Nervous System EU DMF availableUS DMF no. 26266 availableCEP available Indication: Carbamazepine is an anticonvulsant and mood-stabilizing drug used primarily in the treatment of epilepsy and bipolar disorder, as well as trigeminal neuralgia.
Distribution Areas
OceaniaNorth America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
Poland
Polpharma GroupPolpharma Group is a high quality European pharma manufacturer and a reputable business partner for companies worldwide at every stage of product development, manufacturing & commercialization (FDF, API, CDMO, CMO). Polpharma API is a Poland-based CDMO of APIs, and significant European API producer, delivering products to more than 65 countries on 6 continents. We run with $45-million manufacturing expansion to include HPAPI and cryogenic technologies and investments in a pilot plant and R&D capabilities.

Log in

See all the content and easy-to-use features by logging in or registering!